Trial intelligence / Profile preview

Pharmacotherapies for Tobacco Dependence

NCT00332644Phase 4Completed

Sponsor
University of Wisconsin–Madison
Start
Sep 2004
Primary completion
Aug 2010
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nicotine patch, bupropion in nicotine dependence, sponsored by University of Wisconsin–Madison. Started Sep 2004; status: completed.

02

Drugs

nicotine patchbupropion
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT00332644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00332644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call